The global semen analysis systems market is expected to reach USD 1.9 billion by 2035, driven by increased awareness of male infertility and the growing adoption of assisted reproductive technologies such as IVF and IUI. The market is projected to grow at a CAGR of 4.9%, with semen analysis systems becoming essential in assessing sperm quality, motility, and DNA fragmentation. Automated systems are becoming the preferred choice for high throughput, standardized testing in fertility clinics and diagnostic laboratories. In addition, the human semen analysis sector is expected to account for 64.1% of the total revenue in 2025, reflecting the market’s focus on reproductive health diagnostics. The diagnostic laboratories segment is projected to hold 39.8% of the market revenue in 2025, driven by investments in laboratory infrastructure, training, and advanced diagnostic tools, and the adoption of precision semen analysis systems.